23 May 2013
Keywords: novartis, exelon, gets, positive, opinion, eu, cmph
Article | 06 February 2006
Swiss drug major Novartis has received a positive opinion from Europe's Committee for Medicinal Products for Human Use recommending that, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 February 2006
22 May 2013
© 2013 thepharmaletter.com